COMMUNIQUÉS West-GlobeNewswire

Sight-Restorative Eye Donations and Transplants in Colorado and Wyoming Break Records

18/01/2018 - 18:32

DENVER, Jan. 18, 2018 (GLOBE NEWSWIRE) -- The number of eye donations in Colorado and Wyoming, and the number of sight-restorative corneal transplants performed as a result, were at an all-time high in 2017. According [...]

NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2017 Financial Results Conference Call

18/01/2018 - 17:40

WALTHAM, Mass., Jan. 18, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO ) announced today that it plans to issue its fourth quarter and full year 2017 financial results before the opening of the market on [...]

Paratek Announces Pricing of Public Offering of Common Stock

18/01/2018 - 15:41

BOSTON, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK ), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon its expertise in [...]

Imaging3 Announces Formation of a Scientific Advisory Board

18/01/2018 - 15:30

BURBANK, Calif., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Imaging3, Inc. (OTCQB:IGNG), a development stage company targeting disruptive technologies in the medical imaging industry, announced today the formation of a [...]

FIT Biotech Oy: FIT Biotech's CEO to change - Erkki Pekkarinen appointed as a new CEO

18/01/2018 - 15:06

FIT Biotech Oy Company release January 18, 2018 at 4.05 pm EET FIT Biotech's CEO to change - Erkki Pekkarinen appointed as a new CEO The Board of Directors of FIT Biotech Oy (the "Company") has appointed Vice Chairman [...]

Rexahn Pharmaceuticals to Present at the American Society of Clinical Oncology Gastrointestinal Cancers (ASCO GI) 2018 Annual Meeting

18/01/2018 - 15:00

ROCKVILLE, Md., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, [...]

Lexington Completes IRB Submission in Preparation for Clinical Study

18/01/2018 - 15:00

VANCOUVER, British Columbia, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is pleased to announce it [...]

Clinical Genomics appoints Tadd Lazarus, M.D., as Chief Medical Officer

18/01/2018 - 14:30

BRIDGEWATER, N.J., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer diagnostic solutions and liquid biopsy tests, today announced the appointment of Tadd Lazarus, M.D., as Chief Medical [...]

Vilacto Bio Inc. Begins Development of the Vilacto Bio Skincare Knowledge Center

18/01/2018 - 14:30

COPENHAGEN, Denmark, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTCQB:VIBI), today announced that it has commenced development of the Vilacto Bio Skincare Knowledge Center, an online resource that will gather [...]

Xtant Medical Enters into Restructuring and Exchange Agreement with All Holders of Outstanding Convertible Notes

18/01/2018 - 14:30

Conversion of $1.627M (plus interest) of convertible notes into common stock Exchange of $70.238M (plus interest) of convertible notes into common stock Upon stockholder approval, amendment of Certificate of [...]

Canada House Wellness Group Update on Abba Medix Grow Progress

18/01/2018 - 14:29

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Abba Medix Corp “Abba”, a subsidiary of Canada House Wellness Group Inc. (CSE:CHV) (“ [...]

Organovo Announces Release Date for Fiscal Third-Quarter 2018 Financial Results

18/01/2018 - 14:05

SAN DIEGO, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO ) (“Organovo”) will host a conference call on Thursday, February 8, 2018 at 5:00 p.m. Eastern Time (ET) to discuss the Company's fiscal [...]

Celsion Corporation Provides Corporate Update and 2018 Outlook

18/01/2018 - 14:00

Company Advances ThermoDox® for Treatment of Primary Liver Cancer Following Independent Data Monitoring Committee’s Unanimous Recommendation to Continue Phase III OPTIMA Study OPTIMA Study Enrollment Reached 74% [...]

Radient Technologies Inc. Announces Key Management Appointment to RTI Global Health and Wellness Solutions

18/01/2018 - 14:00

EDMONTON, Alberta, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. ("Radient" or the “Corporation”) (TSX-V: RTI ) is pleased to announce the appointment of Dr. Marilena Radoiu to a key management role in its [...]

Argos Announces One-for-Twenty Reverse Stock Split

18/01/2018 - 14:00

DURHAM, N.C., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (NASDAQ: ARGS ), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis [...]

Caladrius Biosciences Announces Completion of Enrollment of Phase 2 T-Rex Clinical Trial of CLBS03 for Type 1 Diabetes

18/01/2018 - 14:00

BASKING RIDGE, N.J. , Jan. 18, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]

AzurRx BioPharma Announces Receipt of Required Approvals to Add French Clinical Site for its Phase IIa Study of MS1819-SD for Exocrine Pancreatic Insufficiency

18/01/2018 - 14:00

BROOKLYN, N.Y., Jan. 18, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]

DiaMedica Letter to Shareholders

18/01/2018 - 14:00

MINNEAPOLIS, Jan. 18, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (“ DiaMedica ”) (TSX VENTURE:DMA) (OTCQB:DMCAF), provides corporate update. As we enter into 2018, we wanted to thank you, our shareholders, for [...]

REPEAT: Cannabis Wheaton Income Corp. Announces Closing of $100 Million Private Placement of Convertible Debenture Units

18/01/2018 - 13:30

VANCOUVER, British Columbia, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V:CBW) (" Wheaton Income " or the " Company ") is pleased to announce the closing of its [...]